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CiliopathyThe last 10 years has witnessed an explosion in research into roles of cilia in cystic renal disease. Cilia are
membrane-enclosed ﬁnger-like projections from the cell, usually on the apical surface or facing into a lumen,
duct or airway. Ten years ago, themajor recognised functions related to classical “9+2” cilia in the respiratory
and reproductive tracts, where co-ordinated beating clears secretions and assists fertilisation respectively.
Primary cilia, which have a “9+0” arrangement lacking the central microtubules, were anatomical curiosities
but several lines of evidence have implicated them in both true polycystic kidney disease and other cystic
renal conditions: ranging from the homology between Caenorhabditis elegans proteins expressed on sensory
cilia to mammalian polycystic kidney disease (PKD) 1 and 2 proteins, through the discovery that orpk cystic
mice have structurally abnormal cilia to numerous recent studies wherein expression of nearly all cyst-
associated proteins has been reported in the cilia or its basal body. Functional studies implicate primary cilia in
mechanosensation, photoreception and chemosensation but it is the ﬁrst of these which appears most
important in polycystic kidney disease: in the simplest model, ﬂuid ﬂow across the apical surface of renal cells
bends the cilia and induces calcium inﬂux, and this is perturbed in polycystic kidney disease. Downstream
effects include changes in cell differentiation and polarity. Pathways such as hedgehog and Wnt signalling
may also be regulated by cilia. These data support important roles for cilia in the pathogenesis of cystic kidney
diseases but one must not forget that the classic polycystic kidney disease proteins are expressed in several
other locations where they may have equally important roles, such as in cell-cell and cell-matrix interactions,
whilst it is not just aberrant cilia signalling that can lead to de-differentiation, loss of polarity and other
characteristic features of polycystic kidney disease. Understanding how cilia ﬁt into the other aspects of
polycystic kidney disease biology is the challenge for the next decade. This article is part of a Special Issue
entitled: Polycystic Kidney Disease.stic Kidney Disease.
ll rights reserved.© 2011 Elsevier B.V. All rights reserved.1. Cilia and ﬁrst links to PKD
Cilia are ﬁnger-like projections from the cell surface bounded by
modiﬁed cell membrane [1]. They contain a microtubule cytoskeleton
in the ciliary axoneme, comprising either 9 peripheral doublets and 2
central microtubules (9+2 arrangement) or just the 9 peripheral
pairs (9+0; Fig. 1). van Leeuwenhoek provided the ﬁrst description
of cilia around 300 years ago and, until recently, most vertebrate cilia
research focussed on 9+2 motile functions in multi-ciliated epithelia
such as the respiratory and reproductive tracts. Nevertheless, a series
of observers in the mid-late twentieth century reported solitary non-
motile cilia and these were named ‘primary cilia’ by Sorokin in 1968
(see historical review by [2]); electron microscopy conﬁrmed a 9+0microtubule layout but roles of these non-motile cilia remained
obscure until the last decade.
In 1999, Barr and Sternberg were investigating mating behaviour
in Caenorhabditis elegans when they identiﬁed the lov-1 gene, that is
required for sensory response and vulva location [3]. This encodes a
transmembrane protein with homology to human PKD1 and it is
expressed in adult male sensory neuron cilia in the rays, hook and
head; moreover the C. elegans homologue of PKD2 also localises to
these neurons and later work suggests that they function in the same
male sensory behavioural pathway [4]. In 2000, Murcia and colleagues
linked PKD to cilia in the Oak Ridge Polycystic Kidney (orpk) mouse:
they observed that the Tg737 gene is required for left-right axis
determination, and the reason this is impaired in mutants is because
they fail to express the central cilium in ventral node cells in early
development [5]; the node is an early organising centre that
determines laterality, which is variously known as Kupffer's vesicle,
and Hensen's node in different organisms. They named the product of
Tg737, Polaris; an excellent choice in retrospect, based on the
increasing evidence linking cilia and PKD not just to left-right body
symmetry but also epithelial polarity during development.
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Primary cilia are highly specialised, dynamic structures, consisting
of cytoplasm and cell membrane supported by longitudinal microtu-
bules. They are rapidly assembled and disassembled at different
stages of the cell cycle and the microscopical process was well-
described by Sorokin almost 50 years ago: as the cell enters G0, the
centrosome migrates towards the cell surface, the mother centriole
attaches to a Golgi derived vesicle mediated in part by the distal
appendages of the centriole, also known as transition ﬁbres, and the
axoneme of the primary cilium grows from the cell surface into the
lumen [6,7]. The primary cilium is resorbed as cells re-enter the cell
cycle and divide, but regrows as each daughter cell becomes
quiescent. Structurally, lengthening the cilium is analogous to
constructing the ﬁrst crane on a building site with extra components
being transported up the crane, then added to the tip to make it
higher; this is reiterated multiple times until the crane reaches full
height. Transport of the proteins needed to build the cilium occurs by
the same processes as required to build ﬂagella, hence it is termed
intraﬂagellar transport (IFT) and speeds of around 1 μm per second
have been recorded [8]. Movement towards the tip of the cilium isFig. 1. Schematic representation of a primary cilium demonstrating the 9+0 microtubule a
shown on the left and right of the cilium respectively. Also shown are the ciliary pocket, tran
budding from the basal membrane. These vesicles carry receptors, such as Smo, and are re
narrow cilium but scanning electron microscopy reveals many different morphologies includ
cilia in contributing to PKD are summarised below the diagram (see text for details).termed anterograde IFT and depends upon kinesin-2 microtubule
motors, whilst the reverse retrograde transport requires dynein [9].
Disruption of transport in either direction perturbs cilia formation:
defective anterograde movement blocks development whereas
disruption of the dynein motor results in short, stumpy cilia [10].
Moreover, kidney-targeted inactivation of kinesin-2 not only inhibits
renal ciliogenesis but also induces cystic kidney disease [11]. Cilia are
also shorter than normal in the orpk mouse [12]. Cilia assembly may
also be regulated by microRNAs because targeted disruption of the
miRNA enzyme dicer in the collecting ducts disrupts cilia develop-
ment and is associated with cysts [13].
Although the cilium and rest of the cell are both covered by the cell
membrane, there is evidence that there is regulated movement of
both proteins and lipids into the cilium which means that membrane
composition is different in these two areas [14]. A ciliary necklace [7]
and “ciliary pore complex”[15] have been reported in various species,
functioning as barriers through which only selected proteins are
allowed passage into the ciliary compartment. The corollary of this is
that selective transport will increase the concentration of speciﬁc
proteins within cilia which may facilitate targeted interactions—a
kind of molecular meeting place within the organelle. More recently,xonemal structure. Anterograde and retrograde transport via kinesin 2 and dynein 1 is
sition ﬁbres and basal body (see text for details), and as well as vesicles fusing with and
gulated by small GTPases, such as Rab23. Note, most illustrations outline a uniformly
ing this one where the end is slightly distended (also see Figs. 2 and 3). Putative roles of
Fig. 2. Confocal microscopy immunostained for acetylated-α-tubulin of A) normal
human kidney tubule, B) human ADPKD sample and C) human ARPKD sample. A)
Outside of tubule is outlined in yellow to aid visualisation; clear apical cilia (green
arrows), although morphology is difﬁcult to distinguish because the lumen is not
dilated and the cilia overlap. B) and C) Several apical cilia projecting into the cyst lumen.
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sion of the plasma membrane in which the primary cilium is rooted
[16]: the pocket shares many morphological features with the
ﬂagellar pocket of Trypanosomatids, which is a trafﬁcking-specialised
membrane domain at the base of the ﬂagellum. The pocket is observed
around virtually all primary cilia in mouse retinal pigment epithelial
cells but it cannot be absolutely essential for function since it is not
universal in kidney cells [16]. A critical component of this diffusion
barrier at the base of the cilium may be Septin 2, a member of the
guanosine triphosphatase family conserved from yeast [17]. Loss of
this factor disrupts ciliary membrane protein localisation, sonic
hedgehog signalling and ciliogenesis [17]. Septin localisation is, at
least in Xenopus embryos, controlled by the planar cell polarity
protein Fritz, and mutations in human Fritz may contribute to some
cases of Bardet–Biedl and Meckel–Gruber syndromes, conditions in
which cystic kidney disease can also occur [18,19]. Moreover, several
of the Bardet–Biedl syndrome genes (known as the BBSome) are
crucial for targeting proteins to the cilium [20].
3. Ciliopathy—a new class of disease
It is not just in classical PKD, however, that malformed or
malfunctioning cilia have been linked to renal cyst development:
Ciliopathy is a whole new disease classiﬁcation that has ‘evolved’ over
the last 5 years, with signiﬁcant genetic and molecular discoveries in
areas such as the Bardet–Biedl and Nephronophthisis groups [21,22].
Full coverage of these is beyond the scope of this review but the
unifying feature of ciliopathies is that the mutated proteins are all
normally expressed in either primary cilia or centrosomes. This is not
necessarily just in the kidney but can also include non-renal sites such
as the photoreceptor cells in the eye, which are modiﬁed cilia.
Widespread distribution of these affected proteins explains the wide
variety of phenotypes in addition to renal cystic disease which include
situs inversus (as one might expect from defective node cilia
function), retinitis pigmentosa and retinal degeneration, hepatic
disease, polydactyly and mental retardation [23].
4. Cilia, ﬂuid ﬂow, calcium and PKD
Polycystin-1 and -2 localise to the primary cilium of diverse cell
types, but vertebrates lacking functional polycystins do not have
structurally abnormal cilia. We have now generated original data
showing that this is true for both humans (Fig. 2) and several of the
animal models such as the congenital polycystic kidney mouse (cpk;
Fig. 3). This suggests that polycystins maymodulate sensory functions
of cilia, rather than cilia formation. The ﬁrst hint that this role may be
mediated by sensing ﬂuid ﬂow and calcium inﬂux came from non-
renal studies looking at laterality determination: loss of Pkd2 causes
randomisation of organ laterality both in mice and zebraﬁsh, which is
thought to result from abnormal signal transduction in peripheral
monocilia of the node (the mammalian “laterality organ”[24–26].
Mechanical bending of individual cilia using micropipettes induces
calcium inﬂux [27], hence it was postulated that consistent directional
ﬂuid ﬂow generated by cilia in the node bends these cilia to induce
polycystin-dependent calcium signalling in the paraxial mesoderm to
the left of the node [25,28–30]. Moving to the kidney, ﬂuid ﬂow also
induces calcium inﬂux in cultured Madin-Darby Canine Kidney cells
(derived from collecting duct epithelia), and this requires intact cilia,
as well as Polycystin-1 and -2; this inﬂux leads to calcium-induced
calcium release from the endoplasmic reticulum mediated via the
ryanodine and inositol triphosphate receptors [24,31–33].
Howmight bending of cilia and aberrant calcium signalling lead to
cyst formation? One suggestion is that lower intracellular calcium in
mutant renal epithelial cells may lead to reduced clearance of
intracellular cAMP (for review see [34]), which is supported by
elevated levels of cAMP in renal cystic epithelia [35]. Downstreameffects may include activation of map kinase signalling, leading to
increased cell proliferation and abnormal ﬂuid secretion, both
contributing to cyst formation. Fluid ﬂow may also regulate gene
expression directly, because it causes phosphorylation and nuclear
export of the transcriptional co-repressor HDAC5, leading to upregu-
lation ofMef2c; this may be relevant, because formation of renal cysts
can be rescued in some strains following knockdown of Mef2c[36].
Furthermore, Foxj1a, a master regulator of cilia formation, and its
downstream targets are upregulated following cystic distension of
zebraﬁsh pronephric ducts and in Ift88−/− renal cystic epithelia,
leading to increased ciliary beating [37]. Therefore, ﬂuid ﬂow may
modulate cilia function, which could further contribute to the
progression of renal cyst formation.
5. Cilia and mTOR
The link between mTOR signalling, PKD and ciliary biology began
with the identiﬁcation of the tuberous sclerosis (TSC) genes, TSC1 and
TSC2 [38,39], which encode Hamartin and Tuberin, respectively.
Fig. 3. Scanning electron microscopy of cpk cystic kidneys at low (A), medium (B) and high magniﬁcation (C and D). Note the different length and morphology of the cilia within
diverse epithelia.
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cilium and basal body [24,40–42]. TSC is an autosomal dominant
condition characterised by the formation of hamartomas in multiple
tissues and organs. Renal cysts form in ~30% of patients with TSC,
while a minority of these patients develop severe PKD. The TSC2 and
PKD1 genes lie adjacent to one another on human chromosome
16p13.3, and contiguous deletions of both genes have been identiﬁed
in patients with this early onset ADPKD [43]. This observation
suggests that TSC and PKD genes interact functionally in the
pathogenesis of PKD, which is supported by the observation that
loss of one allele of Pkd1worsens the renal cystic phenotype of Tsc1+/
− and Tsc2+/− mice [41].
TSC1 and 2 form a complexwith Rheb, a small GTPase belonging to
the Ras superfamily. This TSC complex is inhibited in response to
PI3K/Akt signalling. PI3K (phosphatidyl-inositol 3-kinase) is activated
following binding of various ligands to their cognate receptor,
including members of the tyrosine kinase receptor family. Activation
of PI3K leads to the conversion of phosphatidyl-inositol 2-phosphate
(PIP2) into phosphatidyl-inositol 3-phosphate (PIP3), which in turn
leads to phosphorylation of Akt (forming pAkt) by protein dependent
kinase-1 (PDK1). At the centre of this cascade is mTOR complex 1
(mTORC1), which is composed of mTOR and Raptor. mTORC1
activates a variety of cellular processes, such as growth and
proliferation, via activation of serine 6-kinase (S6K). TSC1 and 2
heterodimerise to form a Rheb GTPase-activating protein, which is
inhibitory to mTORC1, and phosphorylation of TSC2 by pAkt promotes
mTOR signalling by inhibiting the TSC/Rheb complex. Therefore TSC1
and 2 regulate mTOR signalling bymodulating activity of the PI3K/Akt
kinase signalling cascade.
mTORC1 is also implicated in renal cyst formation, because
readouts of mTOR signalling, such as phospho-S6K and -mTOR, are
elevated in epithelial cells lining cysts in kidney samples taken from
patients with ADPKD and ARPKD, and from mouse models of renalcystic disease [44–47]. Furthermore, rapamycin, a speciﬁc inhibitor of
mTORC1, causes regression of renal cysts in several rodent models of
PKD, suggesting a role for mTOR signalling in pathogenesis [44,48–
50]. mTOR signalling is also elevated in renal cystic epithelia of mice
with mutations in genes implicated in ciliogenesis, including Tg737/
Ift88 and Ofd1, and regression of renal cysts in these mice following
rapamycin treatment suggests that cilia may regulate mTOR signalling
during cyst formation [44,51].
The C-terminal cytoplasmic tail of Polycystin-1 regulates the sub-
cellular localisation of Tuberin via a direct physical interaction, and
modulates phosphorylation of TSC2 by AKT [44,45]. Because Poly-
cystin-1 and TSC1 localise to the cilium and basal body, respectively,
and cilia formation is abnormal in both mouse embryonic ﬁbrobalsts
and renal tubular epithelium lacking either Tsc1 or Tsc2[40,41,45],
regulation of mTOR signalling by polycystins may relate to functions
that converge on the cilium. Indeed, bending of cilia has recently been
shown to down-regulate mTOR signalling, independent of both
calcium inﬂuxes and Akt [52]. Regulation of mTOR signalling may be
independent of cilia in some circumstances, however, because Dere et
al. reported that HEK-293 and hTERT RPE-1 cells lacked cilia in their
culture conditions [45].
6. Cilia, Wnt and cell polarity
Diverse recent studies conﬁrm that knockdown of ciliogenesis
genes disruptsWnt signal transduction inmouse, zebraﬁsh and frog. A
number of Wnt signalling pathways have been described, which can
be grouped into canonical or non-canonical pathways, but signalling
is typically initiated by interaction of different Wnt ligands with
speciﬁc Frizzled (Fz) receptors, followed by recruitment of the
intracellular protein, Dishevelled (Dvl), and activation of speciﬁc co-
receptors [53,54]. While canonical Wnt signalling results in activation
of β-catenin-mediated transcription, non-canonical pathways are, by
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pathway may be linked to calcium inﬂux via bending the cilium but
a better studied pathway is Wnt/planar cell polarity (PCP) which
regulates cell migration and polarity.
In the canonical pathway, mice overexpressing β-catenin in renal
epithelia develop cysts, owing to defects in cell turnover and aberrant
localisation of ion channels [55]. The cytoplasmic tail of Polycystin-1
interacts with β-catenin and may modulate Wnt signalling, although
there are conﬂicting results over whether this is stimulatory or
inhibitory [56,57]. Secreted Frizzled-related protein 4, which specif-
ically inhibits canonical Wnt signalling, is upregulated in human
ADPKD and several mouse models of renal cystic disease, and genetic
variation of DKK3, encoding a Wnt/β-catenin antagonist, may modify
the severity of ADPKD [58,59]. Therefore, canonical Wnt signalling is
directly implicated in renal cystic disease.
Wnt/PCP signalling is activated by ligands, such as Wnt11 and
Wnt9b, which are essential for normal kidney development. Wnt11 is
expressed in ureteric ampullae, where it activates Gdnf/Ret signalling
and branching morphogenesis [60]. Furthermore, loss of Wnt9b, or
the PCP protein Fat4, leads to renal cystic disease associated with
abnormal polarity of renal epithelia, randomised orientation of cell
division and abnormal elongation of tubules [61,62]. Epithelial cell
intercalation drives elongation of renal tubules in embryonic
development, whereas direction of cell division is more important
postnatally since themitotic spindles are orientated in the direction of
tubule elongation after birth. Both of these processes are disrupted in
mouse models of renal cystic disease, including mice with mutations
in Hnf1β, Tsc1/2 and Pkd1[41,63]. Several ciliopathy genes have been
implicated in the regulation of Wnt/β-catenin andWnt/PCP signalling
pathways, and work in zebraﬁsh and frogs has controversially
suggested that these components may regulate the balance between
canonical and non-canonical signalling, possibly through regulation of
Dvl, which is common to both pathways; furthermore, this balance
may be regulated by ﬂuid ﬂow [9,64]. Therefore, cilia may coordinate
Wnt signalling pathways, and deregulated wnt signalling may
contribute to cyst formation.
7. Cilia and hedgehog signalling
Cilia play a central role in hedgehog (Hh) signal transduction. The
canonical Hh signalling cascade elicits quantitative transcriptional
responses within cells according to the extracellular concentration of
secreted Hh morphogen (for review see [65]). Hh signalling is
relatively simpler than other signalling cascades, with only three
essentially equivalent morphogens (Sonic (Shh), Indian (Ihh) and
Desert (Dhh) hedgehog) that bind predominantly to only a single
receptor, Patched 1 (Ptch1) [66]. Unlike most other signalling
pathways, this Hh receptor does not induce intracellular signal
transduction upon binding of ligand, but instead serves as an inhibitor
of a second transmembrane protein, Smoothened (Smo), in the
absence of morphogen. Ligand binding leads to derepression of Smo,
allowing it to accumulate in cilia and to activate a series of events that
lead to the conversion of the Gli transcription factors, Gli2 and Gli3,
from transcriptional repressors to transcriptional activators [65].
Recent evidence suggests that transport of Smo along the ciliary
axoneme causes it to undergo conformational change, and leads to
release of Gli2 and Gli3 from cilia into the nucleus [67–69]. Therefore,
cilia are essential for proper regulation of Hh signalling, and various
mutants that exhibit defective ciliogenesis show abnormal gradients
of Hh pathway activity (i.e. elevated Hh signalling in tissues not
normally eliciting a Hh response, and reduced signalling in tissues
normally showing high levels of Hh signal transduction; e.g. the
Joubert syndrome gene, Arl13b [70]). Therefore, abnormal Hh
signalling may result from defective ciliogenesis, observed in renal
cystic epithelia. It is likely that cilia represent a site at which many
components of the Hh and other signalling pathways becomeconcentrated, making it a ‘molecular meeting place’ that promotes
targeted interactions owing to the juxtaposition of the ciliary
axoneme and specialised membrane.
Abnormal Hh signalling in humans is associated with abnormal
renal development. In particular, ectopic and cystic kidneys are
commonly found in Smith–Lemli–Opitz syndrome (SLOS), which is
caused by mutations in DHCR7, which may affect Hh signalling via
defective cholesterol biosynthesis [71–74]. Reduced Hh signalling is
also associated with ectopic kidneys and formation of renal cysts in
mice [75], although it is not clear whether renal cyst formation in
these mice is a direct result of abnormal signalling within the kidney
itself. Other experiments have suggested a role for elevated Hh
signalling within renal epithelia in renal cyst formation. Ihh, which in
contrast to Shh is normally expressed in outer medullary and cortical
collecting duct epithelia [76], was identiﬁed as the most highly up-
regulated gene in a renal explant model of corticosteroid-induced
renal cyst formation [77]. Cyst formation in this model was reduced
following treatment with the Smo antagonist cyclopamine, implicat-
ing canonical Hh signalling in pathogenesis.
Bearing in mind the essential role of cilia in regulating the Hh
cascade, these data linking Hh signalling in renal cystic diseases
suggest that Hh effects may be mediated by ciliary functions.
However, these are observations rather than deﬁnite causal links, so
a thorough analysis of Hh signalling inmodels of PKDwith normal and
abnormal cilia is necessary.
8. Cilia are unlikely to be the only cause of cystic kidneys
In this review, we have presented a ‘cilia-centric’ view of renal
cystic disease. There is overwhelming evidence that cilia are involved
in many cystic diseases, but we would question whether they are the
sole cause of PKD pathogenesis. There are threemain lines of evidence
supporting critical cystogenic roles for cilia: 1) the protein products of
Polycystins and ciliopathy genes localise to cilia and mutations in
these genes are associated with renal cystic disease accompanied by
functional or structural abnormalities in cilia; 2) both polycystin and
ciliopathy gene products regulate signal transduction cascades, and
these pathways are demonstrably abnormal in cystic epithelia; and, 3)
rescue of these cilia-related pathways inhibits cyst formation.
Localisation of the Polycystins to the cilium and ciliopathy genes
within the cilium is tantalising evidence that disruption of cilia is
important cyst formation, but these molecules are all expressed in
other sites too. Polycystins and ﬁbrocystin, for example are found in
focal adhesion complexes, and there is a signiﬁcant body of PKD work
on aberrant cell-matrix and matrix-matrix interactions [78,79] which
cannot all be due to malfunctioning cilia. Similarly, although
ciliopathy genes are expressed in the cilium by deﬁnition, it is now
clear that these genes also regulate a variety of cellular processes
external to the cilium, including cell division and cytoskeletal
organisation [80]; although some of these functions are via the basal
body and centriole [81] which are part of the “cilium complex,” it is
difﬁcult to conceive that all of the effects are cilia mediated when
expression is so much more diverse than this organelle. What if the
ciliary expression of some of these factors is just coincidental, because
they are randomly distributed throughout the plasma membrane?
This might explain why, if you look hard enough, almost every protein
implicated in PKD appears to be expressed in the cilium. Distribution
cannot be completely random, however, because there is deﬁnitely
restricted passage and targeting of some molecules to the cilium
[14,17,20]. The evidence linking aberrant formation of cilia to cystic
kidney disease is compelling in the orpk mouse and several of the IFT
mutants [5,11,12] althoughnot all of these (or theother ciliopathies) get
devastating PKD as is seen with the human PKD mutations. There is
some high quality work on functions such as ﬂow-mediated calcium
inﬂux [24], but these studies are technically difﬁcult and many
laboratories do not have the technology to dissect more subtle ﬂow-
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not possible to speciﬁcally ablate cilia without disrupting other cellular
processes. Moreover, cilia may have a different structure and modiﬁed
functions in normal and cystic epithelia, which makes it difﬁcult to
distinguish cause from effect. As an example, cilia are morphologically
normal in precystic epithelial cells of Ofd1mutant mice but are shorter
in cystic epithelia [51]; so is it the change in cilia length that stimulates
cyst formation or is it the cystic dilatation and changes within the cystic
epithelia that disrupt cilia structure secondarily? Similarly, in TSC and
othermodels, mTOR signalling is upregulated in cystic but not precystic
epithelia [41], and there is a suspicion that rapamycin may be more
effective in already formed cysts rather than at earlier stages. This effect
has been attributed to increased apoptosis in cystic epithelia [44] and it
may help explain the lack of success of recent human rapamycin trials
where therewasamodest reduction inkidney volumewithout rescueof
renal function [82,83].
Overall, the last decade has undoubtedly implicated cilia in renal
cyst biology but the challenge for the next decade is to determine how
cilia-related effects tie in to all of the other facets of PKD biology in
order to devise rational treatments for human disease.
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